Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,603,247
+$1,228,214 QoQ
Shares Held
276,422
+478.6% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 76.18460180448734.ToString("F0")%
Shared 0.ToString("F0")%
None 23.815398195512657.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Man Group plc holds $362,228,781 across 31 Drug Manufacturers - Specialty & Generic names. XERS ranks #20 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
783,624 | $92,632,192 | |
| 2 | VTRS |
Viatris Inc
|
4,092,860 | $55,294,537 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
415,909 | $54,791,850 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
77,495 | $45,952,984 | |
| 5 | ALKS |
Alkermes plc.
|
625,046 | $22,101,626 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
208,694 | $16,048,568 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,293,300 | $12,312,216 | |
| 8 | PRGO |
PERRIGO Co plc
|
986,046 | $10,590,134 |
All Filings in XERS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,603,247 | 276,422 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $375,033 | 47,775 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $611,064 | 130,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $962,106 | 175,247 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $439,840 | 199,023 | Shares | Defined | 2024-05-15 | |
| 2022-03-31 | $1,125,841 | 439,782 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,859,228 | 1,658,440 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||